NCT06652971View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Food Effect of CKD-379

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 4, 2024

Study Completion Date

December 17, 2024

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

CKD-379

QD, PO

Trial Locations (1)

07590

Bumin Hospital, Gangseo-gu

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY